Sutro Biopharma (STRO) Change in Account Payables (2017 - 2025)

Sutro Biopharma has disclosed Change in Account Payables across 9 years of filings, most recently posting $575000.0 for Q4 2025.

• Change in Account Payables for Q4 2025 came in at $575000.0, down 86.05% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.5 million (down 449.58% YoY), and the FY2025 annual result was -$2.5 million, down 449.58% from the prior year.
• Change in Account Payables came in at $575000.0 for Q4 2025 at Sutro Biopharma, down from $2.7 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $4.1 million in Q4 2024 to a low of -$3.8 million in Q2 2025.
• The 5-year median for Change in Account Payables is -$292500.0 (2021), against an average of $226650.0.
• Across the five-year window, Change in Account Payables plunged 1058.08% in 2024 and soared 2281.3% in 2025, its largest moves.
• Sutro Biopharma's Change in Account Payables stood at -$1.8 million in 2021, then soared by 47.24% to -$937000.0 in 2022, then soared by 532.98% to $4.1 million in 2023, then climbed by 1.58% to $4.1 million in 2024, then plunged by 86.05% to $575000.0 in 2025.
• The last three Change in Account Payables figures came in at $575000.0 (Q4 2025), $2.7 million (Q3 2025), and -$3.8 million (Q2 2025), per Business Quant data.